---
title: "IDE, Investigational Device Exemption | MedTech Terms"
description: "FDA authorization to use an investigational device in a clinical study. Plain-English Clinical &amp; Trials definition for MedTech teams, with examples and related"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/ide#term",
        "name": "Investigational Device Exemption",
        "alternateName": "IDE",
        "description": "An Investigational Device Exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a PMA or 510(k) submission to FDA.",
        "url": "https://medtechterms.com/terms/ide",
        "termCode": "ide",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/ide#article",
        "headline": "IDE, Investigational Device Exemption",
        "description": "FDA authorization to use an investigational device in a clinical study.",
        "url": "https://medtechterms.com/terms/ide",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/ide"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/ide#term"
        },
        "articleSection": "Clinical & Trials",
        "inLanguage": "en",
        "keywords": "Investigational Device Exemption, IDE, Clinical & Trials, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "21 CFR Part 812",
            "url": "https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-812",
            "publisher": {
              "@type": "Organization",
              "name": "eCFR"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "ISO 14155 Standard Page",
            "url": "https://www.iso.org/standard/71690.html",
            "publisher": {
              "@type": "Organization",
              "name": "ISO"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "FDA - Clinical Trials and Human Subject Protection",
            "url": "https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection",
            "publisher": {
              "@type": "Organization",
              "name": "FDA"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/pma#term",
            "name": "Premarket Approval",
            "alternateName": "PMA",
            "url": "https://medtechterms.com/terms/pma"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/irb#term",
            "name": "Institutional Review Board",
            "alternateName": "IRB",
            "url": "https://medtechterms.com/terms/irb"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Clinical & Trials",
            "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Investigational Device Exemption",
            "item": "https://medtechterms.com/terms/ide"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/ide#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "What is the primary purpose of an IDE?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "The primary purpose of an Investigational Device Exemption (IDE) is to allow the use of an investigational device in a clinical study to gather safety and effectiveness data needed for regulatory submissions like a Premarket Approval (PMA) or 510(k) to the FDA."
            }
          },
          {
            "@type": "Question",
            "name": "What is the difference between a significant risk and non-significant risk device study regarding IDEs?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Significant risk (SR) device studies require explicit FDA IDE approval and Institutional Review Board (IRB) approval. Non-significant risk (NSR) studies, on the other hand, only require IRB approval and must meet abbreviated IDE requirements, as described in 21 CFR 812.2(b)."
            }
          },
          {
            "@type": "Question",
            "name": "Who approves an IDE?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "The FDA approves an Investigational Device Exemption for significant risk device studies. For non-significant risk studies, the IDE is considered in effect 30 days after IRB approval, provided the abbreviated requirements are met."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials)
6.  /
7.  Investigational Device Exemption

[All terms](/terms)

Clinical & Trials [Clinical Evidence](/ecosystems/clinical-evidence)[Global Markets](/ecosystems/global-markets)IDE 

# Investigational Device Exemption

FDA authorization to use an investigational device in a clinical study.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

An Investigational Device Exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a  [PMA](/terms/pma) or 510(k) submission to FDA. 

What the regulation says

The FDA, under 21 CFR Part 812, outlines the requirements for an Investigational Device Exemption (IDE). These regulations govern clinical studies conducted to collect safety and effectiveness data on medical devices. The primary goal of an IDE is to permit the interstate shipment of investigational devices for research purposes. 

## What this means in practice

Significant risk (SR) device studies require an FDA-approved IDE and  [IRB](/terms/irb) approval. Non-significant risk (NSR) studies require IRB approval and abbreviated IDE requirements. 

## Examples

-   A company developing a novel implantable cardiac device applies for a full IDE from the FDA prior to initiating a clinical trial to evaluate its safety and efficacy.
-   A researcher conducting a study on an existing, legally marketed device for a new indication with minimal risk obtains IRB approval and follows abbreviated IDE requirements, without needing explicit FDA IDE approval.
-   A start-up developing a new diagnostic imaging device submits an IDE application to the FDA, detailing the study protocol, device description, and investigator qualifications.

Common pitfalls

-   • Failing to distinguish between significant risk and non-significant risk device studies can lead to incorrect application of IDE regulations. 
-   • Assuming that IRB approval alone is sufficient for all investigational device studies, neglecting FDA IDE requirements. 
-   • Not understanding the abbreviated IDE requirements for non-significant risk devices can result in unnecessary administrative burden. 
-   • Improperly classifying a device's risk can lead to non-compliance with FDA regulations for clinical investigations. 
-   • Beginning a clinical study without proper IDE approval or exemption can result in regulatory action by the FDA. 

## Frequently asked questions

What is the primary purpose of an IDE? 

The primary purpose of an Investigational Device Exemption (IDE) is to allow the use of an investigational device in a clinical study to gather safety and effectiveness data needed for regulatory submissions like a  [Premarket Approval](/terms/pma) (PMA) or 510(k) to the FDA. 

What is the difference between a significant risk and non-significant risk device study regarding IDEs? 

Who approves an IDE? 

## Cross-references

### Used by

Things that build on this term.

-   [
    
    Premarket Approval(PMA) 
    
    
    
    ](/terms/pma)

### Precedes

Comes before in a typical workflow or lifecycle.

-   [
    
    IDE Supplement
    
    
    
    ](/terms/ide-supplement)

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Clinical & Trials

Institutional Review Board(IRB) 

Board that reviews and approves human-subjects research at an institution.





](/terms/irb)[

Regulatory

Premarket Approval(PMA) 

FDA's most stringent device marketing application, required for high-risk Class III devices.





](/terms/pma)

### Clinical Trials & Evidence

· From this learning path 

[

Clinical & Trials

IDE Supplement

Amendment to an approved Investigational Device Exemption for protocol or device changes.

Adjacent lesson 

](/terms/ide-supplement?from=clinical-trials-and-evidence)[

Clinical & Trials

Adaptive Trial Design

Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data.





](/terms/adaptive-trial?from=clinical-trials-and-evidence)[

Clinical & Trials

Adverse Event(AE) 

Any untoward medical occurrence in a subject, whether or not related to the device.





](/terms/adverse-event?from=clinical-trials-and-evidence)[

Clinical & Trials

Clinical Evaluation Report(CER) 

Documented assessment of clinical data demonstrating EU MDR conformity for a device.





](/terms/cer?from=clinical-trials-and-evidence)

### More in Clinical & Trials

· Same category 

[

Clinical & Trials

Feasibility Study

Small clinical study evaluating initial safety, usability, and design parameters of an investigational device.





](/terms/feasibility-study)[

Clinical & Trials

IDE Annual Progress Report

Annual report sponsors must submit to FDA summarizing the progress of an approved IDE study, including enrollment, deviations, and adverse events.





](/terms/ide-annual-report)

Cited by

Where this term appears across MedTech Terms.

Learning paths (1)

-   [Clinical Trials & Evidence](/paths/clinical-trials-and-evidence)Lesson 1 of 18 

Ecosystems (2)

-   [Clinical Evidence](/ecosystems/clinical-evidence)
-   [Global Markets](/ecosystems/global-markets)

## Mentioned in recent activity

1 entry 

Trials (1)

[AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE ](https://clinicaltrials.gov/study/NCT07277946)

Tissium · 2026-05-14 

## Latest in MedTech

[View all](/latest?term=ide)

Recent regulatory actions, publications, and trials matched to this term. Updated daily.

-   Trial 2026-05-14 
    
    [AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE ](https://clinicaltrials.gov/study/NCT07277946)
    
    Tissium · RECRUITING
    

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

eCFR· 1 ISO· 1 FDA· 1 

1.  [1 
    
    21 CFR Part 812
    
    Verified 
    
    eCFR · ecfr.gov 
    
    
    
    ](https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-812)
2.  [2 
    
    ISO 14155 Standard Page
    
    Verified 
    
    ISO · iso.org 
    
    
    
    ](https://www.iso.org/standard/71690.html)
3.  [3 
    
    FDA - Clinical Trials and Human Subject Protection
    
    Verified 
    
    FDA · fda.gov 
    
    
    
    ](https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Clinical evidence intersecting with device security?

We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Clinical & Trials

Acronym

IDE

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=ide)

Learn in 60 seconds

Card Lesson Quiz

FDA authorization to use an investigational device in a clinical study.

-   · Significant risk (SR) device studies require an FDA-approved IDE and IRB approval. 
-   · Non-significant risk (NSR) studies require IRB approval and abbreviated IDE requirements. 

Remember this

Watch out: Failing to distinguish between significant risk and non-significant risk device studies can lead to incorrect application of IDE regulations.

Related terms

-   [Premarket Approval(PMA) ](/terms/pma)
-   [Institutional Review Board(IRB) ](/terms/irb)

You may also need

Auto-suggested from Clinical & Trials and shared keywords.

-   [Feasibility Study ](/terms/feasibility-study)
-   [Investigator Brochure(IB) ](/terms/investigator-brochure)
-   [Pivotal Trial ](/terms/pivotal-trial)
-   [Clinical Evaluation Plan(CEP) ](/terms/clinical-evaluation-plan)
-   [Electronic Data Capture(EDC) ](/terms/edc)
-   [First-in-Human Study(FIH) ](/terms/fih)

[All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials)

From the Blue Goat network

Related resources and services on this topic.

-   [
    
    MedTech Launchpad 
    
    MedTech funding rounds, accelerators, and launch resources.
    
    ](https://medtechlaunchguide.com)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)